Literature DB >> 6146807

Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response.

B M Hall, G A Bishop, G G Duggin, J S Horvath, J Philips, D J Tiller.   

Abstract

Whether the expression of DR antigens is altered in cadaver renal transplants was examined by the use of monoclonal antibodies to the non-polymorphic region of the DR molecule and an indirect immunoperoxidase stain. Expression of DR antigens increased considerably on renal tubular cells in all 25 biopsy specimens which showed severe cellular rejection, but in only 4 of 14 biopsy specimens with no or minimum evidence of rejection. 2 of these 4 specimens were from patients recently treated for severe rejection and the other 2 subsequently lost their grafts from chronic rejection. DR antigens were also expressed on the cell surface of isolated tubular cells aspirated from transplanted kidneys with acute cellular rejection but not on tubular cells in normal kidneys or aspirates from kidneys without rejection. Biopsy specimens with increased DR expression in tubules usually had an interstitial T cell infiltrate. Expression of DR antigens on tubular cells was not related to HLA-DR incompatibility between donor and host, or to the type of immunosuppressive therapy given. The expression of DR antigens on renal tubular cells may be induced by the infiltrating activated T cells or be a consequence of tubular regeneration following rejection or ischaemic damage. The increased expression of DR antigens on renal tubular cells during rejection makes these cells potential targets for delayed type hypersensitivity responses, which are only effective against DR antigen bearing cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146807     DOI: 10.1016/s0140-6736(84)90297-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Induction of HLA-DR expression on human myoblasts with interferon-gamma.

Authors:  R Hohlfeld; A G Engel
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

Review 3.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

4.  Mononuclear cells in acute allograft glomerulopathy.

Authors:  T V Tuazon; E E Schneeberger; A K Bhan; R T McCluskey; A B Cosimi; R T Schooley; R H Rubin; R B Colvin
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

Review 5.  Tubular and interstitial factors in the progression of glomerulonephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

6.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

7.  Monocyte infiltration and kidney allograft dysfunction during acute rejection.

Authors:  R Girlanda; D E Kleiner; Z Duan; E A S Ford; E C Wright; R B Mannon; A D Kirk
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

Review 8.  Antibody imaging in the evaluation of cardiovascular diseases.

Authors:  B A Khaw; J Narula
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

Review 9.  Regulation and role of thyroid cell class II antigen expression.

Authors:  A P Weetman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

10.  T-lymphocyte subsets in gut and blood of liver transplant recipients with and without cytomegalovirus gastroenteritis.

Authors:  D H Van Thiel; K N Chen; M C Chien; V J Dindzans; J S Gavaler; T L Whiteside
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.